trial
as of 2026-07-01Personalized and Scalable Cognitive Remediation Approaches
NCTId NCT01945333
at a glance
— · Completed
Enrollment 122 (actual)
Primary completion 2017-10-02
Synthesized from structured facts only — each point cited above.
Design & status
Phase
—
Status
Completed
Enrollment
122 (actual)
Study type
Interventional
Allocation
Randomized
Model
Parallel
Masking
Single
Start
2013-09
Primary completion
2017-10-02
Eligibility
ALL · 18 Years · 65 Years
Interventions & indications
Sponsors
Investigators
1
Alice Medalia, PhDPrincipal Investigator
Sites
5 total
Brooklyn, United StatesBrooklyn, United StatesNew York, United StatesNew York, United StatesThe Bronx, United States
Facts & assertions
4 sourced
Enrollment
122
Phase
NA
Primary Completion Date
2017-10-02
Status
COMPLETED
relationships
The graph out of here
drug
lead_sponsor
collaborator
indication
investigator
person